Company: ATHE
Filing Date: 2025-08-29
Form Type: 20-F
Source: 0001213900-25-082027
Chunk: 160

Company: ALTERITY THERAPEUTICS LTD
Filing Date: 2025-08-29
Form: 20-F
Item: Item 18
Chunk 160
---

   At June 30, 2024, the Group had the following cash accounts:   
●   A$11,529,456 in an Australian dollar cash maximiser account at an interest rate of 2.7% as of June 30, 2024;
----------------------------------------------------------------------------------------------------------------
●   A$705,952 in an Australian dollar transaction account at an interest rate of 0.00% as of June 30, 2024;     
●   A$182,048 in an Australian dollar transaction account at an interest rate of 0.00% as of June 30, 2024;     
●   U.S.$138,388 (A$207,581) in U.S. checking accounts at an interest rate of 0.00% as of June 30, 2024;        
●   U.S.$12,094 (A$18,141) in U.S. Airwallex accounts at an interest rate of 0.00% as of June 30, 2024          
●   (A$4,293) in a Visa Credit card account at an interest rate of 0.00% as of June 30, 2024.                   
   At June 30, 2023, the Group had the following cash accounts:   
●   A$27,457 in an Australian dollar cash maximiser account at an interest rate of 1.44% as of June 30, 2023; 
--------------------------------------------------------------------------------------------------------------
●   A$61,518 in an Australian dollar transaction account at an interest rate of 0.00% as of June 30, 2023;    
●   A$18,864 in an Australian dollar transaction account at an interest rate of 0.00% as of June 30, 2023;    
●   U.S.$10,279,099 (A$15,473,231) in U.S. checking accounts at an interest rate of 0.00% as of June 30, 2023;
●   A$42,713 in a 90 days term deposit at a fixed interest rate of 3.85% which matures on August 28, 2023;    
●   A$150,000 in a 90 days term deposit at a fixed interest rate of 3.85% which matures on September 2, 2023; 
     The weighted average interest rate is 3.36% for cash and cash equivalents and